Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000129245 | SCV000184004 | benign | Hereditary cancer-predisposing syndrome | 2024-02-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000507748 | SCV000600461 | uncertain significance | not provided | 2021-04-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000552536 | SCV000635139 | benign | Hereditary breast ovarian cancer syndrome | 2023-02-10 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000129245 | SCV001353452 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-06-17 | criteria provided, single submitter | clinical testing | |
University of Washington Department of Laboratory Medicine, |
RCV000129245 | SCV003849822 | likely benign | Hereditary cancer-predisposing syndrome | 2023-03-23 | criteria provided, single submitter | curation | Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673). |
BRCAlab, |
RCV003493451 | SCV004244159 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 2020-03-02 | no assertion criteria provided | clinical testing |